Catechol (1,2-dihydroxybenzene) is a major phenolic compound present in the co-carcinogenic fraction of
cigarette tar. It has been shown to be a potent co-
carcinogen with
benzo[a]pyrene (BaP) in mouse skin. In this study we have examined the co-carcinogenic and co-initiating activities of
catechol with racemic and enantiomeric 7,8-dihydroxy-7,8-dihydrobenzo[a]
pyrenes (BaP-7,8-diols) in mouse skin. Similar to enhancement of BaP
carcinogenesis, repeated concurrent applications of
catechol and (+/-)-BaP-7,8-diol to mouse skin strongly enhanced (+/-)-BaP-7,8-diol
tumor multiplicity and
tumor incidence, and decreased latency. Co-application of
catechol with the racemic or either of the enantiomers of BaP-7,8-diol in a two-stage initiation--promotion protocol increased the
tumor initiating activity of racemic BaP-7,8-diol, similar to that of BaP, by approximately 50%, but had no statistically significant effect on the
tumor initiating activity of the (+)- or (-)-enantiomers in mouse skin. Thus,
catechol is as potent a co-
carcinogen with (+/-)-BaP-7,8-diol as it is with BaP. However, as tested here
catechol is a weak co-initiator when applied with (+/-)-BaP-7,8-diol or BaP.